The Novavax vaccine candidate also appears to be effective against the UK and South African coronavirus variants.
Author: Karen Weintraub, USA TODAY
New coronavirus variants aren’t cause for alarm yet, but mutations could make COVID-19 harder to fight, experts say
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.
US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use
Moderna’s COVID vaccine, the second cleared for use in the U.S., will be shipped this weekend, with first doses expected to be given Monday.
German scientist Özlem Türeci was focused on cancer, then came COVID-19. It was her ‘duty’ to help develop a vaccine.
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it.
‘No surprises’: 53-page FDA report reinforces safety and effectiveness of Pfizer’s COVID-19 vaccine candidate
FDA summary on Pfizer’s candidate COVID-19 vaccine supports earlier findings that it is safe and will prevent 95% of people from becoming sick.
Moderna becomes second company to request emergency FDA authorization for COVID-19 vaccine candidate
Moderna will be the second coronavirus vaccine maker to request authorization from the government after similarly positive trial results for Pfizer.
COVID-19 vaccine should be ready for most vulnerable late this year, for everyone by spring, HHS Secretary Alex Azar says
During a rare CDC public briefing, HHS Secretary Alex Azar on Wednesday outlined a timeline for the COVID-19 vaccine and pledged it would be safe.
Behind the scenes at the Metropolitan Museum of Art: What does it take reopen a national landmark?
New York City’s famed Metropolitan Museum of Art will welcome guests again after COVID caused it’s longest shutdown in history. What does that take?
How to stop the COVID-19 pandemic? Harvard doc says cheap tests are the answer.
Harvard infectious disease expert Dr. Michael Mina says use of frequent, cheap tests could quell COVID-19 outbreaks in a matter of weeks.